Viral Disease News and Research

RSS

Scientists aim to develop a gene-targeting, antiviral agent against COVID-19

A team of scientists from Stanford University is working with researchers at the Molecular Foundry, a nanoscience user facility located at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), to develop a gene-targeting, antiviral agent against COVID-19.

4 Jun 2020

Exploring data transparency and quality measurements in Austrian healthcare system

A crisis like the corona pandemic demonstrates how important reliable information and transparent communication are, particularly when dealing with such a sensitive area as health.

4 Jun 2020

Study highlights the importance of research-based healthcare in Germany

The authors recommend a needs-based system focusing on patient well-being and quality assurance, rather than a primarily profit-oriented approach. It should appreciate all employees and integrate innovations as well as digital solutions.

2 Jun 2020

How susceptible are domestic animals to SARS-CoV-2?

A recent paper by Chinese researchers, published in the leading journal Science, shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) does not replicate well in dogs, pigs, chickens, and ducks; however, ferrets and cats are easily infected, and cats may transmit the virus via an airborne route.

31 May 2020

The infection of lung stem cells may determine SARS-CoV-2 pathogenicity

A group of researchers from Russia and France has demonstrated how stem cells in the lungs can be readily infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to significant defects in their regeneration capacity and more severe coronavirus disease (COVID-19). Their manuscript is currently available on the preprint server bioRxiv.

25 May 2020

Most Australians do not understand difference between bacterial and viral infection

Public awareness matters amid the coronavirus disease (COVID-19) pandemic; however, a new study shows that more than 92 percent of the Australian population cannot differentiate between a bacterial and viral infection.

18 May 2020

Cats can readily become infected with SARS-CoV-2, confirms study

In a study published today (May 13, 2020) in the New England Journal of Medicine, scientists in the U.S. and Japan report that in the laboratory, cats can readily become infected with SARS-CoV-2, the virus that causes COVID-19, and may be able to pass the virus to other cats.

14 May 2020

Using a smartphone to perform non-invasive at-home testing for COVID-19

In Pennsylvania and other U.S. states, one of the keys to safely reopening society amid the COVID-19 pandemic is providing sufficient testing so that new cases of the disease do not overwhelm the public healthcare system.

12 May 2020

Tissue engineering can play an important role during COVID-19 pandemic

Tissue engineering has a unique set of tools and technologies for developing preventive strategies, diagnostics, and treatments that can play an important role during the ongoing COVID-19 pandemic.

8 May 2020

Inventor of hepatitis C cure wins prestigious award from University of Edinburgh

A medicinal chemist who found a cure for the viral disease hepatitis C has received a prestigious award from the University of Edinburgh.

3 May 2020

Coatings network works towards improving pandemic-readiness

In a world where global warming and long-distance travel quickly spread infectious diseases like COVID-19, innovative germ-killing coatings for hospitals could save lives

28 Apr 2020

CEL-SCI collaborates with UGA Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy

CEL-SCI Corporation announced today it has signed a collaboration agreement with the University of Georgia’s Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy.

23 Mar 2020

Now over 1,200 coronavirus cases in the U.S.

The coronavirus pandemic (COVID-19) started in Wuhan City, Hubei Province, in China in the last month of 2019 and had so far spread to more than 100 countries, including the United States. The country has seen a sharp spike in confirmed cases, which now totals 1,220, trailing behind hotspot countries that have thousands of confirmed cases of the contagious disease.

11 Mar 2020

Study confirms coronavirus median incubation period at 5.1 days

Since the start of the novel coronavirus outbreak in late December 2019, doctors and health officials have imposed a quarantine period of 14 days since the estimated incubation period of the virus was expected to be between three and 14 days. A new study affirms that it may take about five days after exposure before patients manifest the symptoms of the disease.

10 Mar 2020

Italy to isolate 16 million people as country grapples with COVID-19

Italy is grappling with the coronavirus disease (COVID-19) spread in the country, which has so far taken 366 lives and infected 7,375 people. Now, the government plans to isolate and quarantine the northern part of Italy, including Milan and the epicenter of the virus spread, Lombardy, affecting about 16 million people.

9 Mar 2020

Growing concerns of coronavirus should spur plans – not panic – in the workplace

Chances are, if you work for a large company, you received an email like one sent to Volkswagen employees Monday: Coronavirus concerns mean some limits on business travel, everyone should remember to "wash your hands frequently" and stay home if sick.

28 Feb 2020

Social media users most misinformed about vaccines

With the advent of the coronavirus outbreak and other viral outbreaks that are taking the lives of many people worldwide, vaccination is more important today than ever. But, recently, immunization rates have drastically decreased due to information people receive through social media platforms.

18 Feb 2020

Individual response to Ebola predicted by new method

The Ebola virus produces widely varying reactions, from asymptomatic illness to death, in people depending on the individual's susceptibility. But what drives this difference in response? A new study published in the journal Cell Reports on February 2020 goes one step further in understanding how the immune system reacts to the virus causing varying levels of severity of disease between cases.

11 Feb 2020

Bats' fierce immune response to viruses could drive zoonotic emergence

It's no coincidence that some of the worst viral disease outbreaks in recent years -- SARS, MERS, Ebola, Marburg and likely the newly arrived 2019-nCoV virus -- originated in bats.

10 Feb 2020

Genetically engineered mosquitoes halt Dengue spread

A new study published in the journal PLOS Pathogens in January 2020 reports the development of mosquitoes that have been genetically modified to resist infection by several types of the dengue virus. This is the first time ever that all types of the virus have been targeted by the engineering of the mosquito DNA. Covering all virus types is essential to achieve proper disease control.

16 Jan 2020